228 related articles for article (PubMed ID: 29974848)
1. Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study.
Shuaichen L; Guangyi W
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):70-74. PubMed ID: 29974848
[TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
3. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
5. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
6. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
7. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
8. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
9. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
[TBL] [Abstract][Full Text] [Related]
10. Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
Qiang R; Zhao Z; Tang L; Wang Q; Wang Y; Huang Q
Comput Math Methods Med; 2021; 2021():9991255. PubMed ID: 34603487
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
Zhang X; Yin S; Ma K
J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
[TBL] [Abstract][Full Text] [Related]
12. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC.
Wu C; Qi X; Qiu Z; Deng G; Zhong L
Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
14. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
15. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
Zhang Y; Tang Y; Guo C; Li G
Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
[TBL] [Abstract][Full Text] [Related]
16. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
[No Abstract] [Full Text] [Related]
18. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
[TBL] [Abstract][Full Text] [Related]
20. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
Yang MR; Zhang Y; Wu XX; Chen W
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
